Sabine Zimmermann-Tischer

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Journal: JAMA neurology

Published: January 20, 2026

Virus-specific T-cell therapy for neuroinvasive West Nile virus.

Virus-specific T-cell therapy for neuroinvasive West Nile virus.

Journal: The Lancet. Neurology

Published: November 29, 2025

Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies.

Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies.

Journal: Molecular therapy. Oncology

Published: April 22, 2025

Transfer of Herpes Simplex Virus Type 1 (HSV-1) Specific T Cells in a Pediatric Patient Post-HSCT With Severe, Acyclovir-resistant HSV-1 Infection.

Transfer of Herpes Simplex Virus Type 1 (HSV-1) Specific T Cells in a Pediatric Patient Post-HSCT With Severe, Acyclovir-resistant HSV-1 Infection.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 04, 2024

Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy.

Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy.

Journal: JAMA neurology

Published: October 07, 2024

Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report.

Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report.

Journal: Therapeutic advances in neurological disorders

Published: January 13, 2024

Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunity.

Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunity.

Journal: HLA

Published: October 27, 2023

Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISM.

Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISM.

Journal: Blood advances

Published: July 05, 2023

Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case Report.

Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case Report.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 15, 2023

Adenoviral Penton and Hexon Proteins Are Equivalent Immunogenic Targets of Virus-Specific T Cells after Hematopoietic Stem Cell Transplantation in Children.

Adenoviral Penton and Hexon Proteins Are Equivalent Immunogenic Targets of Virus-Specific T Cells after Hematopoietic Stem Cell Transplantation in Children.

Journal: Transplantation and cellular therapy

Published: December 08, 2022

Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.

Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.

Journal: The Journal of clinical investigation

Published: July 14, 2022

Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedure.

Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedure.

Journal: Frontiers in immunology

Published: July 13, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026